Table 3.
Factors associated with CPFE.
| Variables | OR (95%CI) | P value | Adjusted OR (95%CI) | P value |
|---|---|---|---|---|
| Age | 1.01 (0.97–1.05) | 0.693 | ||
| Gender (male) | 2.97 (0.68–13.07) | 0.149 | ||
| Smoking status (current smoker) | 3.52 (0.78–15.93) | 0.103 | ||
| Smoking status (former smoker) | 3.57 (0.79–16.08) | 0.097 | ||
| Pack years |
1.00 (0.99–1.01) |
0.919 |
||
| Comorbidities | ||||
| Lung cancer | 0.61 (0.33–1.15) | 0.127 | ||
| Rheumatic diseases | 3.43 (1.47–8.02) | 0.004 | 4.13 (1.22–13.94) | 0.022 |
| Pulmonary hypertension | 0.66 (0.29–1.49) | 0.313 | ||
| Hypertension | 0.93 (0.50–1.75) | 0.829 | ||
| Coronary heart disease | 0.85 (0.42–1.74) | 0.656 | ||
| Cerebrovascular diseases | 1.29 (0.49–3.41) | 0.607 | ||
| Diabetes | 1.54 (0.76–3.11) | 0.230 | ||
| Tuberculosis | 0.81 (0.41–1.59) | 0.531 | ||
| Chronic liver diseases |
0.68 (0.19–2.43) |
0.557 |
||
| Blood test | ||||
| Hb | 1.01 (0.99–1.02) | 0.506 | ||
| Neut | 0.95 (0.86–1.05) | 0.295 | ||
| Lymph | 0.82 (0.51–1.32) | 0.419 | ||
| Eos | 2.83 (0.57–14.16) | 0.205 | ||
| Plt | 1.00 (0.99–1.00) | 0.043 | 1.00 (0.99–1.00) | 0.064 |
| ALB | 0.98 (0.93–1.04) | 0.544 | ||
| LDH | 1.00 (1.00–1.00) | 0.436 | ||
| TBIL | 1.01 (0.98–1.05) | 0.459 | ||
| INR | 10.27 (1.65–64.07) | 0.013 | 4.18 (0.43–40.38) | 0.216 |
| CRP | 1.00 (1.00–1.00) | 0.387 | ||
| ESR | 1.01 (1.00–1.02) | 0.102 | ||
| C3 | 1.00 (1.00–1.00) | 0.139 | ||
| C4 | 1.00 (0.99–1.00) | 0.482 | ||
| TC | 0.82 (0.64–1.06) | 0.137 | ||
| HDL-C | 0.35 (0.13–0.98) | 0.045 | 0.42 (0.12–1.44) | 0.582 |
| KL-6/100 (U/mL) | 1.11 (1.05–1.17) | <0.001 | 1.11 (1.04–1.17) | 0.001 |
Abbreviations: Hb, hemoglobulin; Neut, neutrophil; Lymph, Lymphocyte; Eos, eosinophil; PLT, platelet; ALB, Albumin; LDH, Lactate dehydrogenase; TBIL, Total bilirubin; INR, International normalized ratio; CRP, C-reaction protein; ESR, erythrocyte sedimentation rate; C3, complement C3; C4, complement C4; TC, total cholesterol; HDL-C, High density lipoprotein cholesterol; KL-6, Krebs Von den Lungen-6.